BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BioPharm Asia, Inc. Announces Hospital Management Contract


12/19/2011 8:38:20 AM

NEW YORK, NY and TONGHUA, CHINA--(Marketwire - December 19, 2011) - BioPharm Asia (PINKSHEETS: BFAR) and Elite Capital Group announced today the signing of a consulting agreement for the development of a 1,000-bed Fangzhuang Hospital and Training Center to be located in Fangzhuang, Beijing. BioPharm Asia will serve as master consultant for the project which is scheduled to begin construction in 2012.

Xiayang Hu, CEO of BioPharm Asia, said, "We are delighted to confirm Elite Capital Group's contract in which our Hospital Management Division will provide key development services as well as assist in the operations of the facility. We are confident that we have the range of skills and services to help Elite Capital Management create new models of healthcare and flexible therapeutic environments."

Andrew Lee, Partner & Managing Director of Elite Capital Group, said, "Substandard healthcare is changing in China, especially the rapid economic progress has improved the financial well being of china's growing middle class. The demands of courteous healthcare professionals in the residential area have risen sharply. Our focus is to pursue this major phenomenon in the Chinese healthcare marketplace and with the help of BioPharm Asia's hospital management expertise to develop a chain of efficient, clean, well-maintained hospitals."

About BioPharm Asia, Inc.

BioPharm Asia, Inc. is engaged in the retail sale of medical products in China, complemented by vertically integrated supporting functions that include the cultivation of Chinese herbal medicines, pharmaceutical production and wholesale medicine distribution. For more information, please visit http://www.biopharmasiainc.com.


For more information:
BioPharm Asia, Inc.
Gloria Fang
(86) 135-3407-3970
Email Contact



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES